Reims, France. – In her invited presentation Dr. Gomord reviewed new avenues in allergy immunotherapy. http://ciaballergie.org/
Read More
News
Orlando, FL. -High level executive exchanges were held with select veterinary pharmaceutical companies from around the world, particularly with regards to ANGANY’s canine atopic dermatitis (CAD) products under development. https://navc.com/vmx/
Canadian pharma start-up enlists LEVOYA to move further into animal health. Animalpharm
Ventura, CA. – Pr. Ronald van Ree and Dr. Guy Tropper presented a scientific poster on behalf of ANGANY’s team and several collaborators at this prestigious, invitation-only scientific meeting gathering…
San Francisco, CA. – ANGANY delegates attended this conference on the latest developments in vaccines and immunotherapy. ANGANY held a presentation titled: “Bioparticle-Potentiated Immunotherapy: Introducing a new bioparticle platform /…
Lévis, QC. – ANGANY is starting operations at this unit set up at AgBioCentre on Mgr Bourget Street in Lévis. This will further progress of process development to its “industrial”…
presented. PhD student Stefanie Busold from Pr. Ronald van Ree’s lab at Amsterdam University Medical Centers presented a scientific poster titled: “Towards Tolerance: Targeting dendritic cells to combat allergic disease.”…
This marks ANGANY’s first corporate sponsorship of a scientific meeting. The International Symposium on Molecular Allergy is a specialty meeting of the European Academy of Allergy and Clinical Immunology held…
Montreal, QC. – Delegates from ANGANY’s executive board attended this forum at the invitation of BCF Business Law.
ANGANY CEO Dr. Louis-Philippe Vézina is pleased to announce the collaboration of Pr. Favrot of the University of Zurich. Pr. Favrot is providing ANGANY with sophisticated insights regarding CAD, an…